These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 18554985)

  • 1. Efficacy and tolerability of pregabalin in patients with difficult-to-treat epilepsy and intellectual disability.
    Huber B; Bocchicchio M; Feuerbaum E; May T; Meinert T; Robertson E; Schorlemmer H; Wagner W; Wilking E; Seidel M
    Epilepsy Behav; 2008 Aug; 13(2):397-401. PubMed ID: 18554985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjunctive pregabalin therapy in mentally retarded, developmentally delayed patients with epilepsy.
    Modur PN; Milteer WE
    Epilepsy Behav; 2008 Oct; 13(3):554-6. PubMed ID: 18579443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and efficacy of two pregabalin regimens for add-on treatment of partial epilepsy.
    Beydoun A; Uthman BM; Kugler AR; Greiner MJ; Knapp LE; Garofalo EA;
    Neurology; 2005 Feb; 64(3):475-80. PubMed ID: 15699378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjunctive pregabalin for uncontrolled partial-onset seizures: findings from a prospective audit.
    Stephen LJ; Parker P; Kelly K; Wilson EA; Leach V; Brodie MJ
    Acta Neurol Scand; 2011 Aug; 124(2):142-5. PubMed ID: 21434875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pregabalin or placebo used adjunctively with levetiracetam in refractory partial-onset epilepsy: a post hoc efficacy and safety analysis in combined clinical trials.
    Uthman BM; Almas M; Emir B; Giordano S; Leon T
    Curr Med Res Opin; 2011 Jul; 27(7):1285-93. PubMed ID: 21561392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical experiences with pregabalin in the treatment of focal epilepsies].
    Gil-Nagel Rein A; Gómez-Alonso J
    Rev Neurol; 2005 May 16-31; 40(10):609-13. PubMed ID: 15926135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pregabalin add-on treatment in patients with partial seizures: a novel evaluation of flexible-dose and fixed-dose treatment in a double-blind, placebo-controlled study.
    Elger CE; Brodie MJ; Anhut H; Lee CM; Barrett JA
    Epilepsia; 2005 Dec; 46(12):1926-36. PubMed ID: 16393158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pregabalin add-on therapy using a flexible, optimized dose schedule in refractory partial epilepsies: a double-blind, randomized, placebo-controlled, multicenter trial.
    Lee BI; Yi S; Hong SB; Kim MK; Lee SA; Lee SK; Shin DJ; Kim JM; Song HK; Heo K; Lowe W; Leon T
    Epilepsia; 2009 Mar; 50(3):464-74. PubMed ID: 19222545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pregabalin as adjunctive therapy for partial seizures.
    Brodie MJ
    Epilepsia; 2004; 45 Suppl 6():19-27. PubMed ID: 15315512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pregabalin as adjunctive therapy for partial epilepsy: an audit study in 96 patients from the South East of England.
    Valentin A; Moran N; Hadden R; Oakes A; Elwes R; Delamont R; Mullatti N; Nashef L
    Seizure; 2009 Jul; 18(6):450-2. PubMed ID: 19213577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pregabalin as add-on therapy for refractory partial seizures in every day clinical practice.
    Carreño M; Maestro I; Molins A; Donaire A; Falip M; Becerra JL; Castillo J
    Seizure; 2007 Dec; 16(8):709-12. PubMed ID: 17604654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiepileptic efficacy of vigabatrin in people with severe epilepsy and intellectual disability.
    Ylinen A
    J Intellect Disabil Res; 1998 Dec; 42 Suppl 1():46-9. PubMed ID: 10030432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness of add-on therapy with pregabalin in patients with refractory partial epilepsy.
    Vera-Llonch M; Brandenburg NA; Oster G
    Epilepsia; 2008 Mar; 49(3):431-7. PubMed ID: 17822431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retention rate of pregabalin in drug-resistant epilepsy: 1-year follow-up, single-centre observation in 105 consecutive, adult patients.
    Brandt C; May TW; Pohlmann-Eden B; Nieder E; Elsner H; Witte-Boelt K; Schuermann I; Ebner A
    Seizure; 2009 Nov; 18(9):634-8. PubMed ID: 19674920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gabapentin in the treatment of refractory partial epilepsy in children with intellectual disability.
    Mikati MA; Choueri R; Khurana DS; Riviello J; Helmers S; Holmes G
    J Intellect Disabil Res; 1998 Dec; 42 Suppl 1():57-62. PubMed ID: 10030434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pregabalin: preliminary experience in intractable childhood epilepsy.
    Jan MM; Zuberi SA; Alsaihati BA
    Pediatr Neurol; 2009 May; 40(5):347-50. PubMed ID: 19380070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pregabalin: a new antiepileptic drug for refractory epilepsy.
    Hamandi K; Sander JW
    Seizure; 2006 Mar; 15(2):73-8. PubMed ID: 16413993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vigabatrin in unsatisfactory controlled epilepsies. Swiss Vigabatrin Study Group.
    Russ W
    Schweiz Arch Neurol Psychiatr (1985); 1995; 146(2):55-9. PubMed ID: 7569836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ambiguous results of an attempt to withdraw barbiturates in epilepsy patients with intellectual disability.
    Huber B; Bocchicchio M; Hauser I; Horstmann V; Jokeit G; May T; Meinert T; Robertson E; Schorlemmer H; Schulz L; Wagner W; Seidel M
    Seizure; 2009 Mar; 18(2):109-18. PubMed ID: 18760938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An open-label, add-on study of pregabalin in patients with partial seizures: a multicenter trial in Greece.
    Tsounis S; Kimiskidis VK; Kazis D; Gkiatas K; Garganis K; Karageorgiou K; Giannakodimos S; Papathanasopoulos P; Plaitakis A; Papadimitriou A; Lyras L; Emir B
    Seizure; 2011 Nov; 20(9):701-5. PubMed ID: 21775167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.